CTLA4 and rheumatoid arthritis: The decreased expression of CTLA-4 in Tregs of RA is compromised by CTLA-4 promoter methylation, resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway (Cribbs et al., 2014).